Trial Profile
A prospective randomized double-blinded split-face trial with BF-200 ALA and MAL in patients with actinic keratoses
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary) ; Methyl aminolevulinate
- Indications Actinic keratosis
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2015 New trial record